| Date Filed | Type | Description |
| 01/23/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 01/21/2022 |
SC 13G
| Tekla Capital Management LLC reports a 7.2% stake in Rallybio Corp. |
| 01/29/2021 |
SC 13G/A
| Tekla Capital Management LLC reports a 0% stake in Zyla Life Sciences |
| 01/24/2020 |
SC 13G
| Tekla Capital Management LLC reports a 7% stake in Zyla Life Sciences |
| 01/24/2020 |
SC 13G/A
| Tekla Capital Management LLC reports a 2.3% stake in ARCA biopharma, Inc. |
| 02/12/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/12/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/12/2018 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/12/2018 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/12/2018 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/13/2017 |
SC 13G
| Tekla Capital Management LLC reports a 154842289% stake in Verona Pharma plc |
| 02/13/2017 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/13/2017 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals [Amend] |
| 02/13/2017 |
SC 13G/A
| PIERIS PHARMACEUTICALS, INC. reports a 4145958% stake in Pieris Pharmaceuticals, Inc. |
| 02/12/2016 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals |
| 02/12/2016 |
SC 13G
| Hambrecht & Quist Capital Management LLC reports a 1650000% stake in Alliqua BioMedical, Inc. |
| 02/12/2016 |
SC 13G
| Marika Inc. reports a 3848191% stake in Pieris Pharmaceuticals, Inc. |
| 02/14/2012 |
SC 13G/A
| Hambrecht & Quist Capital Management LLC reports a 4% stake in MZT Holdings, Inc. |
| 02/14/2012 |
SC 13G/A
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals [amend] |
| 02/14/2012 |
SC 13G
| Hambrecht & Quist Capital Management LLC reports a 9.7% stake in A.P. Pharma, Inc. |
| 02/10/2011 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals |
| 01/22/2010 |
SC 13G/A
| Tekla Capital Management LLC reports a 1% stake in Athersys, Inc. |
| 02/14/2008 |
SC 13G/A
| Form SC 13G/A -- Statement of acquisition of beneficial ownership by individuals [amend] |
| 02/14/2008 |
SC 13G
| Tekla Capital Management LLC reports a 5.2% stake in Athersys Inc. |
| 02/14/2008 |
SC 13G/A
| Hambrecht & Quist Capital Management LLC reports a 1.4% stake in Zix Corporation |
| 01/10/2008 |
SC 13G/A
| Hambrecht & Quist Capital Management LLC reports a 6.8% stake in MZT Holdings, Inc. |
| 02/09/2007 |
SC 13G
| Hambrecht & Quist Capital Management LLC reports a 6.5% stake in Zix Corporation |
| 02/09/2007 |
SC 13G/A
| Hambrecht & Quist Capital Management LLC reports a 4% stake in Avalon Pharmaceuticals, Inc. |
| 02/09/2007 |
SC 13G
| Hambrecht & Quist Capital Management LLC reports a 12.2% stake in Matritech, Inc. |
| 12/11/2006 |
SC 13G
| Hambrecht & Quist Capital Management LLC reports a 11.9% stake in Medwave, Inc. |
| 02/14/2006 |
SC 13G
| Hambrecht & Quist Capital Management LLC reports a 5.5% stake in Avalon Pharmaceuticals, Inc. |
| 02/14/2006 |
SC 13G/A
| Hambrecht & Quist Capital Management LLC reports a 1.3% stake in Senomyx Inc. |
| 02/14/2005 |
SC 13G
| Hambrecht & Quist Capital Management LLC reports a 6.4% stake in VNUS Medical Technologies, Inc. |
| 02/04/2005 |
SC 13G
| Hambrecht & Quist Capital Management LLC reports a 5.7% stake in Senomyx Inc. |